Current Edition

news

Lilly strikes $1.6B deal to buy I-O player Armo Biosciences

Eli Lilly and Co. said it will buy Armo Biosciences Inc. for about $1.6 billion, in an all-cash transaction intended to bolster its immuno-oncology program …

Continue Reading →